nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNH1—embryo—polycystic ovary syndrome	0.0233	0.0405	CbGeAlD
Dalfampridine—KCNS2—uterus—polycystic ovary syndrome	0.0185	0.0321	CbGeAlD
Dalfampridine—KCND1—embryo—polycystic ovary syndrome	0.0173	0.03	CbGeAlD
Dalfampridine—KCNA4—adrenal cortex—polycystic ovary syndrome	0.0156	0.0271	CbGeAlD
Dalfampridine—KCNC2—pituitary gland—polycystic ovary syndrome	0.0154	0.0268	CbGeAlD
Dalfampridine—KCNG1—uterus—polycystic ovary syndrome	0.014	0.0243	CbGeAlD
Dalfampridine—KCNH3—pituitary gland—polycystic ovary syndrome	0.0137	0.0239	CbGeAlD
Dalfampridine—KCNH8—pituitary gland—polycystic ovary syndrome	0.0133	0.0232	CbGeAlD
Dalfampridine—KCNA4—pituitary gland—polycystic ovary syndrome	0.0126	0.0219	CbGeAlD
Dalfampridine—KCNF1—adrenal cortex—polycystic ovary syndrome	0.0121	0.0211	CbGeAlD
Dalfampridine—KCNS1—pituitary gland—polycystic ovary syndrome	0.012	0.0208	CbGeAlD
Dalfampridine—KCNH1—endocrine gland—polycystic ovary syndrome	0.0119	0.0208	CbGeAlD
Dalfampridine—KCNH8—adrenal gland—polycystic ovary syndrome	0.0119	0.0207	CbGeAlD
Dalfampridine—KCNC4—adipose tissue—polycystic ovary syndrome	0.0114	0.0198	CbGeAlD
Dalfampridine—KCNG1—vagina—polycystic ovary syndrome	0.0114	0.0198	CbGeAlD
Dalfampridine—KCNA4—adrenal gland—polycystic ovary syndrome	0.0112	0.0195	CbGeAlD
Dalfampridine—KCNA3—adrenal gland—polycystic ovary syndrome	0.0112	0.0195	CbGeAlD
Dalfampridine—KCNC1—pituitary gland—polycystic ovary syndrome	0.011	0.0191	CbGeAlD
Dalfampridine—KCNF1—endometrium—polycystic ovary syndrome	0.0108	0.0188	CbGeAlD
Dalfampridine—KCNG1—endocrine gland—polycystic ovary syndrome	0.0107	0.0185	CbGeAlD
Dalfampridine—KCNB1—endocrine gland—polycystic ovary syndrome	0.0103	0.0179	CbGeAlD
Dalfampridine—KCNC4—adrenal gland—polycystic ovary syndrome	0.0102	0.0178	CbGeAlD
Dalfampridine—KCNS1—vagina—polycystic ovary syndrome	0.0099	0.0172	CbGeAlD
Dalfampridine—KCNF1—pituitary gland—polycystic ovary syndrome	0.0098	0.017	CbGeAlD
Dalfampridine—KCNF1—adipose tissue—polycystic ovary syndrome	0.00976	0.017	CbGeAlD
Dalfampridine—KCNS3—endometrium—polycystic ovary syndrome	0.00948	0.0165	CbGeAlD
Dalfampridine—KCND1—vagina—polycystic ovary syndrome	0.00947	0.0165	CbGeAlD
Dalfampridine—KCNA2—endocrine gland—polycystic ovary syndrome	0.00927	0.0161	CbGeAlD
Dalfampridine—KCND1—endocrine gland—polycystic ovary syndrome	0.00886	0.0154	CbGeAlD
Dalfampridine—KCNQ5—vagina—polycystic ovary syndrome	0.00885	0.0154	CbGeAlD
Dalfampridine—KCNA5—pituitary gland—polycystic ovary syndrome	0.00876	0.0152	CbGeAlD
Dalfampridine—CYP2E1—urine—polycystic ovary syndrome	0.00866	0.0151	CbGeAlD
Dalfampridine—KCNS3—pituitary gland—polycystic ovary syndrome	0.00858	0.0149	CbGeAlD
Dalfampridine—KCNS3—adipose tissue—polycystic ovary syndrome	0.00855	0.0149	CbGeAlD
Dalfampridine—Chest discomfort—Metformin—polycystic ovary syndrome	0.00829	0.102	CcSEcCtD
Dalfampridine—KCNF1—vagina—polycystic ovary syndrome	0.00811	0.0141	CbGeAlD
Dalfampridine—KCNH6—uterus—polycystic ovary syndrome	0.00797	0.0139	CbGeAlD
Dalfampridine—KCNQ2—pituitary gland—polycystic ovary syndrome	0.0079	0.0137	CbGeAlD
Dalfampridine—KCNQ1—adrenal cortex—polycystic ovary syndrome	0.00781	0.0136	CbGeAlD
Dalfampridine—KCNS3—adrenal gland—polycystic ovary syndrome	0.00766	0.0133	CbGeAlD
Dalfampridine—KCNF1—endocrine gland—polycystic ovary syndrome	0.00759	0.0132	CbGeAlD
Dalfampridine—KCND2—pituitary gland—polycystic ovary syndrome	0.00748	0.013	CbGeAlD
Dalfampridine—KCND2—adipose tissue—polycystic ovary syndrome	0.00745	0.0129	CbGeAlD
Dalfampridine—KCNA5—female gonad—polycystic ovary syndrome	0.0073	0.0127	CbGeAlD
Dalfampridine—KCNA5—vagina—polycystic ovary syndrome	0.00725	0.0126	CbGeAlD
Dalfampridine—KCNS3—vagina—polycystic ovary syndrome	0.0071	0.0124	CbGeAlD
Dalfampridine—KCNA5—endocrine gland—polycystic ovary syndrome	0.00679	0.0118	CbGeAlD
Dalfampridine—KCND3—uterus—polycystic ovary syndrome	0.00664	0.0115	CbGeAlD
Dalfampridine—KCNQ2—female gonad—polycystic ovary syndrome	0.00658	0.0114	CbGeAlD
Dalfampridine—KCND3—adipose tissue—polycystic ovary syndrome	0.00649	0.0113	CbGeAlD
Dalfampridine—KCNQ1—pituitary gland—polycystic ovary syndrome	0.00631	0.011	CbGeAlD
Dalfampridine—KCNQ1—adipose tissue—polycystic ovary syndrome	0.00629	0.0109	CbGeAlD
Dalfampridine—KCND2—female gonad—polycystic ovary syndrome	0.00623	0.0108	CbGeAlD
Dalfampridine—KCNQ2—endocrine gland—polycystic ovary syndrome	0.00612	0.0106	CbGeAlD
Dalfampridine—KCND3—adrenal gland—polycystic ovary syndrome	0.00582	0.0101	CbGeAlD
Dalfampridine—KCNQ1—adrenal gland—polycystic ovary syndrome	0.00564	0.00981	CbGeAlD
Dalfampridine—KCNQ1—female gonad—polycystic ovary syndrome	0.00526	0.00914	CbGeAlD
Dalfampridine—KCNQ1—endocrine gland—polycystic ovary syndrome	0.00489	0.0085	CbGeAlD
Dalfampridine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00476	0.0588	CcSEcCtD
Dalfampridine—Infestation—Metformin—polycystic ovary syndrome	0.0041	0.0507	CcSEcCtD
Dalfampridine—Infestation NOS—Metformin—polycystic ovary syndrome	0.0041	0.0507	CcSEcCtD
Dalfampridine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00362	0.0447	CcSEcCtD
Dalfampridine—Angiopathy—Metformin—polycystic ovary syndrome	0.00334	0.0413	CcSEcCtD
Dalfampridine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00333	0.0411	CcSEcCtD
Dalfampridine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00332	0.041	CcSEcCtD
Dalfampridine—Tremor—Metformin—polycystic ovary syndrome	0.003	0.0371	CcSEcCtD
Dalfampridine—Chest pain—Metformin—polycystic ovary syndrome	0.00273	0.0337	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00271	0.0335	CcSEcCtD
Dalfampridine—KCNH2—endometrium—polycystic ovary syndrome	0.00266	0.00462	CbGeAlD
Dalfampridine—Infection—Metformin—polycystic ovary syndrome	0.0026	0.0321	CcSEcCtD
Dalfampridine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00257	0.0317	CcSEcCtD
Dalfampridine—Skin disorder—Metformin—polycystic ovary syndrome	0.00254	0.0314	CcSEcCtD
Dalfampridine—KCNH2—uterus—polycystic ovary syndrome	0.00245	0.00426	CbGeAlD
Dalfampridine—Hypotension—Metformin—polycystic ovary syndrome	0.00244	0.0302	CcSEcCtD
Dalfampridine—KCNH2—pituitary gland—polycystic ovary syndrome	0.00241	0.00418	CbGeAlD
Dalfampridine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00235	0.029	CcSEcCtD
Dalfampridine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00233	0.0288	CcSEcCtD
Dalfampridine—Dyspepsia—Metformin—polycystic ovary syndrome	0.0023	0.0285	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00226	0.0279	CcSEcCtD
Dalfampridine—Constipation—Metformin—polycystic ovary syndrome	0.00224	0.0276	CcSEcCtD
Dalfampridine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00216	0.0266	CcSEcCtD
Dalfampridine—KCNH2—adrenal gland—polycystic ovary syndrome	0.00215	0.00374	CbGeAlD
Dalfampridine—Urticaria—Metformin—polycystic ovary syndrome	0.00208	0.0257	CcSEcCtD
Dalfampridine—KCNH2—female gonad—polycystic ovary syndrome	0.002	0.00349	CbGeAlD
Dalfampridine—KCNH2—vagina—polycystic ovary syndrome	0.00199	0.00346	CbGeAlD
Dalfampridine—Asthenia—Metformin—polycystic ovary syndrome	0.00188	0.0232	CcSEcCtD
Dalfampridine—KCNH2—endocrine gland—polycystic ovary syndrome	0.00186	0.00324	CbGeAlD
Dalfampridine—Dizziness—Metformin—polycystic ovary syndrome	0.00173	0.0214	CcSEcCtD
Dalfampridine—Vomiting—Metformin—polycystic ovary syndrome	0.00166	0.0206	CcSEcCtD
Dalfampridine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00166	0.00288	CbGeAlD
Dalfampridine—Rash—Metformin—polycystic ovary syndrome	0.00165	0.0204	CcSEcCtD
Dalfampridine—Dermatitis—Metformin—polycystic ovary syndrome	0.00165	0.0204	CcSEcCtD
Dalfampridine—Headache—Metformin—polycystic ovary syndrome	0.00164	0.0203	CcSEcCtD
Dalfampridine—Nausea—Metformin—polycystic ovary syndrome	0.00155	0.0192	CcSEcCtD
Dalfampridine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00144	0.0025	CbGeAlD
Dalfampridine—KCNH7—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000986	0.00287	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—DLG4—polycystic ovary syndrome	0.000985	0.00286	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000956	0.00278	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000956	0.00278	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NMNAT3—polycystic ovary syndrome	0.000956	0.00278	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000924	0.00268	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—RBP4—polycystic ovary syndrome	0.000911	0.00265	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000906	0.00263	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000904	0.00263	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—DLG4—polycystic ovary syndrome	0.000901	0.00262	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—DLG4—polycystic ovary syndrome	0.000901	0.00262	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000891	0.00259	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—DLG4—polycystic ovary syndrome	0.000884	0.00257	CbGpPWpGaD
Dalfampridine—CYP2E1—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000883	0.00257	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000878	0.00255	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SUOX—polycystic ovary syndrome	0.000874	0.00254	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SUOX—polycystic ovary syndrome	0.000874	0.00254	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000874	0.00254	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LPCAT2—polycystic ovary syndrome	0.000874	0.00254	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SUOX—polycystic ovary syndrome	0.000874	0.00254	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000874	0.00254	CbGpPWpGaD
Dalfampridine—CYP2E1—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000849	0.00247	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000829	0.00241	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SUOX—polycystic ovary syndrome	0.000829	0.00241	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ISYNA1—polycystic ovary syndrome	0.000813	0.00236	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000813	0.00236	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000813	0.00236	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000805	0.00234	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000799	0.00232	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—DLG4—polycystic ovary syndrome	0.000788	0.00229	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000771	0.00224	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000767	0.00223	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000757	0.0022	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000757	0.0022	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000722	0.0021	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TEAD2—polycystic ovary syndrome	0.000691	0.00201	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TEAD2—polycystic ovary syndrome	0.000691	0.00201	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1C2—polycystic ovary syndrome	0.000691	0.00201	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000691	0.00201	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TEAD2—polycystic ovary syndrome	0.000691	0.00201	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000691	0.00201	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—DLG4—polycystic ovary syndrome	0.00067	0.00195	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—DLG4—polycystic ovary syndrome	0.00067	0.00195	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000655	0.0019	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000655	0.0019	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000631	0.00183	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000629	0.00183	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000618	0.0018	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00061	0.00177	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—DLG4—polycystic ovary syndrome	0.000594	0.00173	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—DLG4—polycystic ovary syndrome	0.000594	0.00173	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000579	0.00168	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000579	0.00168	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000579	0.00168	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000579	0.00168	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000575	0.00167	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000567	0.00165	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000567	0.00165	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000563	0.00164	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00055	0.0016	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000549	0.0016	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000549	0.0016	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000549	0.0016	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000549	0.0016	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—STAR—polycystic ovary syndrome	0.000524	0.00152	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—STAR—polycystic ovary syndrome	0.000524	0.00152	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—STAR—polycystic ovary syndrome	0.000524	0.00152	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000521	0.00151	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000511	0.00149	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000501	0.00146	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—STAR—polycystic ovary syndrome	0.000497	0.00144	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000495	0.00144	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000477	0.00139	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMMR—polycystic ovary syndrome	0.000467	0.00136	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMMR—polycystic ovary syndrome	0.000467	0.00136	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMMR—polycystic ovary syndrome	0.000467	0.00136	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000466	0.00135	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000455	0.00132	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000455	0.00132	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000454	0.00132	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000449	0.00131	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000445	0.00129	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000445	0.00129	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000445	0.00129	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMMR—polycystic ovary syndrome	0.000443	0.00129	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000437	0.00127	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—DLG4—polycystic ovary syndrome	0.000424	0.00123	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—DLG4—polycystic ovary syndrome	0.000424	0.00123	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000422	0.00123	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000421	0.00122	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000421	0.00122	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LHB—polycystic ovary syndrome	0.000406	0.00118	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LHB—polycystic ovary syndrome	0.000406	0.00118	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LHB—polycystic ovary syndrome	0.000406	0.00118	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000397	0.00116	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000397	0.00116	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000397	0.00115	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000397	0.00115	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000397	0.00115	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LHB—polycystic ovary syndrome	0.000385	0.00112	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000384	0.00112	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000384	0.00112	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000384	0.00112	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000377	0.0011	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000376	0.00109	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000369	0.00107	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000368	0.00107	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000367	0.00107	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000364	0.00106	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—polycystic ovary syndrome	0.000363	0.00106	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000362	0.00105	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000354	0.00103	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000354	0.00103	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000354	0.00103	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—RRM2—polycystic ovary syndrome	0.000343	0.000996	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—RRM2—polycystic ovary syndrome	0.000343	0.000996	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—RRM2—polycystic ovary syndrome	0.000343	0.000996	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000335	0.000975	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—DLG4—polycystic ovary syndrome	0.000334	0.00097	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—YAP1—polycystic ovary syndrome	0.00033	0.00096	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—YAP1—polycystic ovary syndrome	0.00033	0.00096	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—YAP1—polycystic ovary syndrome	0.00033	0.00096	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00033	0.00096	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—RRM2—polycystic ovary syndrome	0.000325	0.000944	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000322	0.000936	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000318	0.000923	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000318	0.000923	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NAMPT—polycystic ovary syndrome	0.000317	0.000923	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NAMPT—polycystic ovary syndrome	0.000317	0.000923	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NAMPT—polycystic ovary syndrome	0.000317	0.000923	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000313	0.000911	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000313	0.000911	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000313	0.000911	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—YAP1—polycystic ovary syndrome	0.000313	0.00091	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000301	0.000875	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000301	0.000874	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000297	0.000864	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000297	0.000864	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000296	0.000862	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000296	0.00086	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000296	0.00086	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000296	0.00086	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000291	0.000847	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000291	0.000847	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000291	0.000847	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000281	0.000816	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000276	0.000803	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000273	0.000795	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00027	0.000783	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000266	0.000774	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000263	0.000763	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—LEP—polycystic ovary syndrome	0.000261	0.00076	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—LEP—polycystic ovary syndrome	0.000261	0.00076	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TH—polycystic ovary syndrome	0.000252	0.000733	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TH—polycystic ovary syndrome	0.000252	0.000733	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TH—polycystic ovary syndrome	0.000252	0.000733	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000248	0.000721	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000248	0.00072	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000245	0.000713	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000245	0.000713	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000245	0.000713	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000244	0.00071	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TH—polycystic ovary syndrome	0.000239	0.000695	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000236	0.000685	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000232	0.000676	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000231	0.00067	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000231	0.00067	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000231	0.00067	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—polycystic ovary syndrome	0.000228	0.000662	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—polycystic ovary syndrome	0.000228	0.000662	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—INS—polycystic ovary syndrome	0.000223	0.000649	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—INS—polycystic ovary syndrome	0.000223	0.000649	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000222	0.000644	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000219	0.000635	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT2—polycystic ovary syndrome	0.000216	0.000627	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT2—polycystic ovary syndrome	0.000216	0.000627	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNAS—polycystic ovary syndrome	0.000206	0.000598	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNAS—polycystic ovary syndrome	0.000206	0.000598	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNAS—polycystic ovary syndrome	0.000206	0.000598	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—polycystic ovary syndrome	0.000198	0.000575	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—polycystic ovary syndrome	0.000198	0.000575	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NCOR1—polycystic ovary syndrome	0.000196	0.00057	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NCOR1—polycystic ovary syndrome	0.000196	0.00057	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NCOR1—polycystic ovary syndrome	0.000196	0.00057	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000196	0.000569	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNAS—polycystic ovary syndrome	0.000195	0.000567	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000193	0.000562	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NCOR1—polycystic ovary syndrome	0.000186	0.00054	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000186	0.00054	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000186	0.00054	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000186	0.00054	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000177	0.000514	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000176	0.000512	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—polycystic ovary syndrome	0.000173	0.000504	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—polycystic ovary syndrome	0.000173	0.000504	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—polycystic ovary syndrome	0.000173	0.000504	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—polycystic ovary syndrome	0.000164	0.000477	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000158	0.000459	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000156	0.000453	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000141	0.00041	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000141	0.00041	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—polycystic ovary syndrome	0.000141	0.000408	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—polycystic ovary syndrome	0.000141	0.000408	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—polycystic ovary syndrome	0.000141	0.000408	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000139	0.000404	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POMC—polycystic ovary syndrome	0.000139	0.000403	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POMC—polycystic ovary syndrome	0.000139	0.000403	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POMC—polycystic ovary syndrome	0.000139	0.000403	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—INS—polycystic ovary syndrome	0.000138	0.000401	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—INS—polycystic ovary syndrome	0.000138	0.000401	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—INS—polycystic ovary syndrome	0.000138	0.000401	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—polycystic ovary syndrome	0.000137	0.000397	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—polycystic ovary syndrome	0.000137	0.000397	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—polycystic ovary syndrome	0.000133	0.000387	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—POMC—polycystic ovary syndrome	0.000131	0.000382	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—INS—polycystic ovary syndrome	0.000131	0.00038	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000127	0.000369	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000127	0.000369	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000122	0.000355	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000118	0.000343	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.000118	0.000342	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.0001	0.000292	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.0001	0.000292	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—polycystic ovary syndrome	9.76e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—polycystic ovary syndrome	9.76e-05	0.000284	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	8.41e-05	0.000245	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	7.98e-05	0.000232	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	7.61e-05	0.000221	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	6.78e-05	0.000197	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	6.47e-05	0.000188	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	5.9e-05	0.000172	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	5.77e-05	0.000168	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	5.59e-05	0.000162	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	5.14e-05	0.000149	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	4.98e-05	0.000145	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	4.8e-05	0.00014	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	4.61e-05	0.000134	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	4.55e-05	0.000132	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	4.3e-05	0.000125	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	4.23e-05	0.000123	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TH—polycystic ovary syndrome	3.66e-05	0.000106	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	3.56e-05	0.000104	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	3.35e-05	9.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	2.99e-05	8.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	2.85e-05	8.28e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	2.7e-05	7.85e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	2.52e-05	7.32e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	2.04e-05	5.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	2.01e-05	5.85e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	2e-05	5.82e-05	CbGpPWpGaD
